EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review

Sandra Caíña López iD, Luciano Martínez Martínez, Andrea Bartolomé Figueroa, Ana Rodríguez Regal

Annals of Pharmacotherapy · 2026

DOI: 10.1177/10600280251407146 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Pharmacotherapy, 2026. Verfasst von Sandra Caíña López und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, University Hospital Complex of Pontevedra, Pontevedra, Spain. Hauptthemen laut MEDLINE: Insulin Resistance, Sphingosine 1 Phosphate Receptor Modulators, Multiple Sclerosis, Sphingosine-1-Phosphate Receptors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective is to review the potential impact of sphingosine-1-phosphate (S1P) receptor modulators on insulin resistance in patients with multiple sclerosis, including underlying mechanisms and clinical evidence. Data sources: A literature search was conducted in PubMed for publications from inception through November 2025. Additional sources, including therapeutic positioning reports and official product information (Summary of Product Characteristics), were also reviewed. Study selection and data extraction: Relevant English and Spanish language articles were extracted and evaluated. Data synthesis: Sphingosine-1-phosphate receptors (S1PR) regulate both immunological and metabolic functions, representing a key therapeutic target in multiple sclerosis. Agents such as fingolimod, siponimod, ozanimod and ponesimod bind to these receptors, thereby preventing lymphocyte migration into the central nervous system. Preclinical evidence suggests that S1P signaling participates in insulin receptor and Akt pathways, affecting glycogen synthesis, glucose uptake and β-cell survival. Clinical experience, including a case of a patient with type 1 diabetes and multiple sclerosis treated with ponesimod, indicates potential increases in insulin requirements and hyperglycemia, although formal human studies are lacking. Relevance to patient care and clinical practice: Clinicians should monitor glycemic control in patients with multiple sclerosis receiving S1PR modulators, especially those with pre-existing metabolic disorders. Awareness of potential insulin resistance may guide drug selection and metabolic management. Further prospective studies are warranted to clarify clinical implications.

Conclusions

S1PR modulators are effective disease-modifying therapies in multiple sclerosis, but emerging evidence suggests a possible impact on insulin signaling and glucose metabolism. Vigilance in metabolic monitoring is recommended, particularly in patients with diabetes or other risk factors for insulin resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceSphingosine 1 Phosphate Receptor ModulatorsMultiple SclerosisSphingosine-1-Phosphate ReceptorsHumansAnimalsFingolimod Hydrochloride

Stichwörter der Autor:innen

drug monitoringdrug safetydrug utilizationinsulinneurology

Substanzen

Sphingosine 1 Phosphate Receptor ModulatorsFingolimod HydrochlorideSphingosine-1-Phosphate Receptors

Autor:innen und Institutionen

  • Department of Hospital Pharmacy, University Hospital Complex of Pontevedra, Pontevedra, Spain.
  • Department of Neurology, University Hospital Complex of Pontevedra, Pontevedra, Spain.

ORCID-Profile: Sandra Caíña López

Zitieren

APA

Caíña López, S., Martínez Martínez, L., Bartolomé Figueroa, A., & Rodríguez Regal, A. (2026). Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251407146

Vancouver

Caíña López S, Martínez Martínez L, Bartolomé Figueroa A, Rodríguez Regal A. Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280251407146

BibTeX
@article{CaaLpez2026,
  author = {Caíña López, Sandra and Martínez Martínez, Luciano and Bartolomé Figueroa, Andrea and Rodríguez Regal, Ana},
  title = {Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review},
  journal = {Annals of Pharmacotherapy},
  year = {2026},
  doi = {10.1177/10600280251407146}
}
Kostenlos starten →